Pharma Reviews: Lupin Q2 Earnings Meet Estimates Despite Pricing Pressure In The US

The Indian pharmaceutical sector has seen pricing pressure in the U.S. due to regulatory issues. “In Q2 we have recorded strong growth in all our ...
Read more: Lupin Q2 Earnings Meet Estimates Despite Pricing Pressure In The US